Mumbai, Jan. 28 -- Total revenue from operations grew by 7.10% year on year (YoY) to Rs 7,072.97 crore in the quarter ended 31 December 2024.

Profit before tax was at Rs 1,916.09 crore in the December quarter of FY25, up 30% from Rs 1,473.81 crore recorded in Q3 FY24.

EBITDA in Q3 FY25 stood at Rs 1,989 crore, registering a growth of 15.7% on YoY basis. EBITDA margin improved to 28.1% as compared to 26.3% recorded in the corresponding quarter previous year.

In Q2 FY25, One India Business grew at a healthy 10% YoY. The branded prescription business continued to outpace the market growth in key therapies, Trade Generics is back on a growth trajectory, and Anchor brands of CHL continued to grow bigger.

The North America business delivere...